Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 4
1982 2
1983 2
1984 2
1985 1
1986 2
1987 4
1988 2
1989 1
1990 1
1991 7
1992 3
1993 6
1994 3
1995 3
1996 2
1997 6
1998 2
1999 3
2000 4
2001 3
2002 6
2003 8
2004 4
2005 7
2006 2
2007 4
2008 8
2009 6
2010 13
2011 12
2012 9
2013 11
2014 6
2015 13
2016 12
2017 16
2018 19
2019 24
2020 28
2021 26
2022 31
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

295 results
Results by year
Filters applied: . Clear all
Page 1
SGLT-2 inhibitors as cardio-renal protective agents.
Caruso I, Giorgino F. Caruso I, et al. Among authors: giorgino f. Metabolism. 2022 Feb;127:154937. doi: 10.1016/j.metabol.2021.154937. Epub 2021 Nov 19. Metabolism. 2022. PMID: 34808144 Review.
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.
Ludvik B, Giorgino F, Jódar E, Frias JP, Fernández Landó L, Brown K, Bray R, Rodríguez Á. Ludvik B, et al. Among authors: giorgino f. Lancet. 2021 Aug 14;398(10300):583-598. doi: 10.1016/S0140-6736(21)01443-4. Epub 2021 Aug 6. Lancet. 2021. PMID: 34370970 Clinical Trial.
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).
Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, Donini LM, Basciani S, Cignarelli A, Conte E, Ceccarini G, Bogazzi F, Cimino L, Condorelli RA, La Vignera S, Calogero AE, Gambineri A, Vignozzi L, Prodam F, Aimaretti G, Linsalata G, Buralli S, Monzani F, Aversa A, Vettor R, Santini F, Vitti P, Gnessi L, Pagotto U, Giorgino F, Colao A, Lenzi A; Cardiovascular Endocrinology Club of the Italian Society of Endocrinology. Caprio M, et al. Among authors: giorgino f. J Endocrinol Invest. 2019 Nov;42(11):1365-1386. doi: 10.1007/s40618-019-01061-2. Epub 2019 May 20. J Endocrinol Invest. 2019. PMID: 31111407
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.
Schnell O, Battelino T, Bergenstal R, Blüher M, Böhm M, Brosius F, Carr RD, Ceriello A, Forst T, Giorgino F, Guerci B, Heerspink HJL, Itzhak B, Ji L, Kosiborod M, Lalić N, Lehrke M, Marx N, Nauck M, Rodbard HW, Rosano GMC, Rossing P, Rydén L, Santilli F, Schumm-Draeger PM, Vandvik PO, Vilsbøll T, Wanner C, Wysham C, Standl E. Schnell O, et al. Among authors: giorgino f. Cardiovasc Diabetol. 2022 Apr 8;21(1):50. doi: 10.1186/s12933-022-01481-0. Cardiovasc Diabetol. 2022. PMID: 35395808 Free PMC article.
New strategies to improve clinical outcomes for diabetic kidney disease.
Forst T, Mathieu C, Giorgino F, Wheeler DC, Papanas N, Schmieder RE, Halabi A, Schnell O, Streckbein M, Tuttle KR. Forst T, et al. Among authors: giorgino f. BMC Med. 2022 Oct 10;20(1):337. doi: 10.1186/s12916-022-02539-2. BMC Med. 2022. PMID: 36210442 Free PMC article. Review.
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study.
Fioretto P, Del Prato S, Buse JB, Goldenberg R, Giorgino F, Reyner D, Langkilde AM, Sjöström CD, Sartipy P; DERIVE Study Investigators. Fioretto P, et al. Among authors: giorgino f. Diabetes Obes Metab. 2018 Nov;20(11):2532-2540. doi: 10.1111/dom.13413. Epub 2018 Jul 10. Diabetes Obes Metab. 2018. PMID: 29888547 Free PMC article. Clinical Trial.
295 results